Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection

Dinusha N. Udukala, Hongwang Wang, Sebastian O. Wendel, Aruni P. Malalasekera, Thilani N. Samarakoon, Asanka S. Yapa, Gayani Abayaweera, Matthew T. Basel, Pamela Maynez, Raquel Ortega, Yubisela Toledo, Leonie Bossmann, Colette Robinson, Katharine E. Janik, Olga B. Koper, Ping Li, Massoud Motamedi, Daniel A. Higgins, Gary Gadbury, Gaohong ZhuDeryl L. Troyer, Stefan H. Bossmann

    Research output: Contribution to journalArticle

    6 Citations (Scopus)

    Abstract

    Proteases, including matrix metalloproteinases (MMPs), tissue serine proteases, and cathepsins (CTS) exhibit numerous functions in tumor biology. Solid tumors are characterized by changes in protease expression levels by tumor and surrounding tissue. Therefore, monitoring protease levels in tissue samples and liquid biopsies is a vital strategy for early cancer detection. Water-dispersable Fe/Fe3O4-core/shell based nanoplatforms for protease detection are capable of detecting protease activity down to sub-femtomolar limits of detection. They feature one dye (tetrakis(carboxyphenyl)porphyrin (TCPP)) that is tethered to the central nanoparticle by means of a protease-cleavable consensus sequence and a second dye (Cy 5.5) that is directly linked. Based on the protease activities of urokinase plasminogen activator (uPA), MMPs 1, 2, 3, 7, 9, and 13, as well as CTS B and L, human breast cancer can be detected at stage I by means of a simple serum test. By monitoring CTS B and L stage 0 detection may be achieved. This initial study, comprised of 46 breast cancer patients and 20 apparently healthy human subjects, demonstrates the feasibility of proteaseactivity- based liquid biopsies for early cancer diagnosis.

    Original languageEnglish (US)
    Pages (from-to)364-373
    Number of pages10
    JournalBeilstein Journal of Nanotechnology
    Volume7
    Issue number1
    DOIs
    StatePublished - 2016

    Fingerprint

    protease
    Iron oxides
    iron oxides
    breast
    Screening
    Peptide Hydrolases
    screening
    Iron
    cancer
    iron
    Cathepsin L
    Tumors
    Cathepsin B
    Biopsy
    Tissue
    tumors
    Coloring Agents
    Dyes
    dyes
    Cathepsins

    Keywords

    • Biophotonics
    • Breast cancer
    • Iron/iron oxide nanoparticle
    • Liquid biopsy
    • Nanodiagnostics detection
    • Nanomedicine
    • Sub-femtomolar limit of detection

    ASJC Scopus subject areas

    • Materials Science(all)
    • Physics and Astronomy(all)
    • Electrical and Electronic Engineering

    Cite this

    Udukala, D. N., Wang, H., Wendel, S. O., Malalasekera, A. P., Samarakoon, T. N., Yapa, A. S., ... Bossmann, S. H. (2016). Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection. Beilstein Journal of Nanotechnology, 7(1), 364-373. https://doi.org/10.3762/bjnano.7.33

    Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection. / Udukala, Dinusha N.; Wang, Hongwang; Wendel, Sebastian O.; Malalasekera, Aruni P.; Samarakoon, Thilani N.; Yapa, Asanka S.; Abayaweera, Gayani; Basel, Matthew T.; Maynez, Pamela; Ortega, Raquel; Toledo, Yubisela; Bossmann, Leonie; Robinson, Colette; Janik, Katharine E.; Koper, Olga B.; Li, Ping; Motamedi, Massoud; Higgins, Daniel A.; Gadbury, Gary; Zhu, Gaohong; Troyer, Deryl L.; Bossmann, Stefan H.

    In: Beilstein Journal of Nanotechnology, Vol. 7, No. 1, 2016, p. 364-373.

    Research output: Contribution to journalArticle

    Udukala, DN, Wang, H, Wendel, SO, Malalasekera, AP, Samarakoon, TN, Yapa, AS, Abayaweera, G, Basel, MT, Maynez, P, Ortega, R, Toledo, Y, Bossmann, L, Robinson, C, Janik, KE, Koper, OB, Li, P, Motamedi, M, Higgins, DA, Gadbury, G, Zhu, G, Troyer, DL & Bossmann, SH 2016, 'Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection', Beilstein Journal of Nanotechnology, vol. 7, no. 1, pp. 364-373. https://doi.org/10.3762/bjnano.7.33
    Udukala, Dinusha N. ; Wang, Hongwang ; Wendel, Sebastian O. ; Malalasekera, Aruni P. ; Samarakoon, Thilani N. ; Yapa, Asanka S. ; Abayaweera, Gayani ; Basel, Matthew T. ; Maynez, Pamela ; Ortega, Raquel ; Toledo, Yubisela ; Bossmann, Leonie ; Robinson, Colette ; Janik, Katharine E. ; Koper, Olga B. ; Li, Ping ; Motamedi, Massoud ; Higgins, Daniel A. ; Gadbury, Gary ; Zhu, Gaohong ; Troyer, Deryl L. ; Bossmann, Stefan H. / Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection. In: Beilstein Journal of Nanotechnology. 2016 ; Vol. 7, No. 1. pp. 364-373.
    @article{e3310c1b36b6449f903c80b00bcdbd3c,
    title = "Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection",
    abstract = "Proteases, including matrix metalloproteinases (MMPs), tissue serine proteases, and cathepsins (CTS) exhibit numerous functions in tumor biology. Solid tumors are characterized by changes in protease expression levels by tumor and surrounding tissue. Therefore, monitoring protease levels in tissue samples and liquid biopsies is a vital strategy for early cancer detection. Water-dispersable Fe/Fe3O4-core/shell based nanoplatforms for protease detection are capable of detecting protease activity down to sub-femtomolar limits of detection. They feature one dye (tetrakis(carboxyphenyl)porphyrin (TCPP)) that is tethered to the central nanoparticle by means of a protease-cleavable consensus sequence and a second dye (Cy 5.5) that is directly linked. Based on the protease activities of urokinase plasminogen activator (uPA), MMPs 1, 2, 3, 7, 9, and 13, as well as CTS B and L, human breast cancer can be detected at stage I by means of a simple serum test. By monitoring CTS B and L stage 0 detection may be achieved. This initial study, comprised of 46 breast cancer patients and 20 apparently healthy human subjects, demonstrates the feasibility of proteaseactivity- based liquid biopsies for early cancer diagnosis.",
    keywords = "Biophotonics, Breast cancer, Iron/iron oxide nanoparticle, Liquid biopsy, Nanodiagnostics detection, Nanomedicine, Sub-femtomolar limit of detection",
    author = "Udukala, {Dinusha N.} and Hongwang Wang and Wendel, {Sebastian O.} and Malalasekera, {Aruni P.} and Samarakoon, {Thilani N.} and Yapa, {Asanka S.} and Gayani Abayaweera and Basel, {Matthew T.} and Pamela Maynez and Raquel Ortega and Yubisela Toledo and Leonie Bossmann and Colette Robinson and Janik, {Katharine E.} and Koper, {Olga B.} and Ping Li and Massoud Motamedi and Higgins, {Daniel A.} and Gary Gadbury and Gaohong Zhu and Troyer, {Deryl L.} and Bossmann, {Stefan H.}",
    year = "2016",
    doi = "10.3762/bjnano.7.33",
    language = "English (US)",
    volume = "7",
    pages = "364--373",
    journal = "Beilstein Journal of Nanotechnology",
    issn = "2190-4286",
    publisher = "Beilstein-Institut Zur Forderung der Chemischen Wissenschaften",
    number = "1",

    }

    TY - JOUR

    T1 - Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection

    AU - Udukala, Dinusha N.

    AU - Wang, Hongwang

    AU - Wendel, Sebastian O.

    AU - Malalasekera, Aruni P.

    AU - Samarakoon, Thilani N.

    AU - Yapa, Asanka S.

    AU - Abayaweera, Gayani

    AU - Basel, Matthew T.

    AU - Maynez, Pamela

    AU - Ortega, Raquel

    AU - Toledo, Yubisela

    AU - Bossmann, Leonie

    AU - Robinson, Colette

    AU - Janik, Katharine E.

    AU - Koper, Olga B.

    AU - Li, Ping

    AU - Motamedi, Massoud

    AU - Higgins, Daniel A.

    AU - Gadbury, Gary

    AU - Zhu, Gaohong

    AU - Troyer, Deryl L.

    AU - Bossmann, Stefan H.

    PY - 2016

    Y1 - 2016

    N2 - Proteases, including matrix metalloproteinases (MMPs), tissue serine proteases, and cathepsins (CTS) exhibit numerous functions in tumor biology. Solid tumors are characterized by changes in protease expression levels by tumor and surrounding tissue. Therefore, monitoring protease levels in tissue samples and liquid biopsies is a vital strategy for early cancer detection. Water-dispersable Fe/Fe3O4-core/shell based nanoplatforms for protease detection are capable of detecting protease activity down to sub-femtomolar limits of detection. They feature one dye (tetrakis(carboxyphenyl)porphyrin (TCPP)) that is tethered to the central nanoparticle by means of a protease-cleavable consensus sequence and a second dye (Cy 5.5) that is directly linked. Based on the protease activities of urokinase plasminogen activator (uPA), MMPs 1, 2, 3, 7, 9, and 13, as well as CTS B and L, human breast cancer can be detected at stage I by means of a simple serum test. By monitoring CTS B and L stage 0 detection may be achieved. This initial study, comprised of 46 breast cancer patients and 20 apparently healthy human subjects, demonstrates the feasibility of proteaseactivity- based liquid biopsies for early cancer diagnosis.

    AB - Proteases, including matrix metalloproteinases (MMPs), tissue serine proteases, and cathepsins (CTS) exhibit numerous functions in tumor biology. Solid tumors are characterized by changes in protease expression levels by tumor and surrounding tissue. Therefore, monitoring protease levels in tissue samples and liquid biopsies is a vital strategy for early cancer detection. Water-dispersable Fe/Fe3O4-core/shell based nanoplatforms for protease detection are capable of detecting protease activity down to sub-femtomolar limits of detection. They feature one dye (tetrakis(carboxyphenyl)porphyrin (TCPP)) that is tethered to the central nanoparticle by means of a protease-cleavable consensus sequence and a second dye (Cy 5.5) that is directly linked. Based on the protease activities of urokinase plasminogen activator (uPA), MMPs 1, 2, 3, 7, 9, and 13, as well as CTS B and L, human breast cancer can be detected at stage I by means of a simple serum test. By monitoring CTS B and L stage 0 detection may be achieved. This initial study, comprised of 46 breast cancer patients and 20 apparently healthy human subjects, demonstrates the feasibility of proteaseactivity- based liquid biopsies for early cancer diagnosis.

    KW - Biophotonics

    KW - Breast cancer

    KW - Iron/iron oxide nanoparticle

    KW - Liquid biopsy

    KW - Nanodiagnostics detection

    KW - Nanomedicine

    KW - Sub-femtomolar limit of detection

    UR - http://www.scopus.com/inward/record.url?scp=84994030761&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84994030761&partnerID=8YFLogxK

    U2 - 10.3762/bjnano.7.33

    DO - 10.3762/bjnano.7.33

    M3 - Article

    AN - SCOPUS:84994030761

    VL - 7

    SP - 364

    EP - 373

    JO - Beilstein Journal of Nanotechnology

    JF - Beilstein Journal of Nanotechnology

    SN - 2190-4286

    IS - 1

    ER -